Skip to main content
Back
Watch Compare

Milestone Pharmaceuticals Inc.

Data quality: 83%
MIST
NASDAQ Manufacturing Chemicals
$2.13
▲ $0.10 (4.68%)
6 months return
—
Momentum
Neutral
ROE
-4576.05%

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-4576.05%
Below sector avg (-54.68%)
ROIC-85.11%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
2.74
Above sector avg (0.30)
Current Ratio8.24
Interest Coverage-16.19

Valuation

PE (TTM|NTM)
-3.63 | -2.36
Below sector avg (-1.50)
P/B Ratio11.16
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Debt/Equity of 2.74 — high leverage
Negative free cash flow of -49.34 M

Price History

Financial Trends

Analyst Price Target

6 analysts
Buy
+205.9%
upside to target
Current
$2.13
Consensus Target
$6.50
$2.00
Low
$8.00
High
Forecast
Forward P/E
-2.36
Forward EPS
-$0.86
Est. Revenue
29.03 M

Earnings Surprises

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -$0.03 · Rev Est: 56.39 M
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -$0.31 -$0.20 -$0.12 -$0.15 — —
Estimate -$0.20 -$0.18 -$0.17 -$0.18 -$0.03 -$0.20
Surprise -58.97% -11.11% +28.00% +15.10% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -4576.05% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -63.06 M
ROE -4576.05% ROA -93.30%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -49.34 M
ROIC -85.11% FCF Growth (3Y) N/A

Safety

D/E: 2.74 · Current: 8.24
Debt / Equity 2.74 Current Ratio 8.24
Interest Coverage -16.19 Asset Turnover N/A
Working Capital 76.15 M Tangible Book Value 20.50 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -3.63 · EV/EBITDA: N/A
P/E Ratio -3.63 Forward P/E -2.36
P/B Ratio 11.16 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 7.88 Fwd Earnings Yield N/A
FCF Yield -21.56%
Market Cap 228.86 M Enterprise Value 238.38 M

Per Share

EPS: -0.75 · FCF/Share: -0.42
EPS (Diluted TTM) -0.75 Revenue / Share N/A
FCF / Share -0.42 OCF / Share -0.42
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 78.25% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 78.25%
SBC-Adj. FCF -54.65 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -63.06 M -41.52 M -59.69 M -58.39 M -42.85 M
EPS (Diluted) -0.75 -0.67 -1.39 — -1.02
Gross Profit — — — — —
Operating Income -62.14 M -42.10 M -61.10 M -59.64 M -43.07 M
EBITDA — — — — —
R&D Expenses 18.11 M 14.36 M 31.05 M 39.83 M 38.67 M
SG&A Expenses — — — — —
D&A 114,000.0 105,000.0 92,000.0 89,000.0 93,000.0
Interest Expense 3.84 M 3.58 M 2.55 M — —
Income Tax — — — — -17,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 113.56 M 75.50 M 75.23 M 74.48 M 119.85 M
Total Liabilities 71.79 M 62.35 M 58.46 M 8.14 M 7.25 M
Shareholders' Equity 41.77 M 13.15 M 16.77 M 66.35 M 112.60 M
Total Debt 57.19 M 53.35 M 49.77 M — —
Cash & Equivalents 73.05 M 25.31 M 13.76 M 7.64 M 114.14 M
Current Assets 111.92 M 73.93 M 73.03 M 71.80 M 118.92 M
Current Liabilities 13.98 M 8.13 M 7.23 M 6.14 M 6.78 M

Peer Comparison

vs Manufacturing sector median (1605 peers)
Metric Stock Sector Median
P/E -3.6 -1.5
P/B 11.2 1.6
ROE % -4576.1 -54.7
Net Margin % — -41.5
Rev Growth 5Y % — 1.7
D/E 2.7 0.3

ETFs Holding This Stock
SURI logo SURI Simplify Propel Opportunities ETF
8.20% weight